Clinical Research Directory
Browse clinical research sites, groups, and studies.
Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
Sponsor: Swedish Medical Center
Summary
Proposed treatment of subjects with newly diagnosed glioblastoma with novel personalized drug regimens identified to be effective in vitro using cancer stem cells derived from their individual tumors, alongside standard of care radiation and TMZ.
Official title: A Phase 1 Study of Combination Drug Therapy Based on Personalized Cancer Stem Cell (CSC) High-Throughput Drug Screening (HTS) With Standard of Care for Newly Diagnosed Glioblastoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-04-19
Completion Date
2027-12
Last Updated
2025-05-16
Healthy Volunteers
No
Conditions
Interventions
combinations of up to 3 FDA approved drugs from a panel of compounds
personalized drug combinations
Locations (1)
Swedish Medical Center
Seattle, Washington, United States